Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Covalon Technologies ( (TSE:COV) ) has provided an announcement.
Covalon Technologies Ltd. has announced it will release its first quarter fiscal 2025 financial results on February 21, 2025, before the market opens. The company will hold a conference call and webcast on the same day at 8:30am ET to discuss the results, allowing participants to ask questions. This announcement could impact the company’s operations and provide insights into its financial health, influencing stakeholders and investors.
More about Covalon Technologies
Covalon Technologies Ltd. is a leading medical device company focused on enhancing patient outcomes through innovative medical products and technologies. The company specializes in advanced wound care, vascular access, and surgical consumables, aiming to improve healing, reduce healthcare-associated infections, and protect skin integrity. It is listed on the TSX Venture Exchange and trades on the OTCQX Market.
YTD Price Performance: -2.88%
Average Trading Volume: 34,601
Technical Sentiment Consensus Rating: Sell
Current Market Cap: C$83.29M
Learn more about COV stock on TipRanks’ Stock Analysis page.
